Literature DB >> 9743823

Palliative care in chronic obstructive airways disease: a needs assessment.

J Skilbeck1, L Mott, H Page, D Smith, S Hjelmeland-Ahmedzai, D Clark.   

Abstract

The view that palliative care should move beyond cancer is widely endorsed, however, there remains a lack of clarity about the level at which this should occur. In order to target the palliative approach effectively, the value of more detailed and localized needs assessment becomes apparent. This paper provides evidence from a study commissioned by a department of public health, where the focus was the palliative care needs of an individual with chronic obstructive airways disease (COAD). Over a six-month period, 63 individuals in the district were interviewed about their experiences of living with COAD and the services utilized, using a combination of qualitative and quantitative research methods. The findings revealed a poor quality of life, relating to a high degree of social isolation and emotional distress, associated with low physical functioning and disability, and physical symptoms. Current service provision focused on acute exacerbations. Consequently, there is a need to manage the health and social care interface more effectively, with a shift in emphasis from reactive ad hoc provision, which is where the palliative approach to care could be best suited to meet the needs identified.

Entities:  

Mesh:

Year:  1998        PMID: 9743823     DOI: 10.1191/026921698677124622

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  26 in total

1.  The new contract: renaissance or requiem for general practice?

Authors:  Martin Marshall; Martin Roland
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

2.  Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Signe Berit Bentsen; Christine Miaskowski; Tone Rustøen
Journal:  Qual Life Res       Date:  2013-09-03       Impact factor: 4.147

3.  Palliative care in primary care: a study to determine whether patients and professionals agree on symptoms.

Authors:  Gail Ewing; Margaret Rogers; Stephen Barclay; Janet McCabe; Anna Martin; Malcolm Campbell; Chris Todd
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

Review 4.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

Review 5.  Palliative care in chronic obstructive pulmonary disease: a review for clinicians.

Authors:  David A Seamark; Clare J Seamark; David M G Halpin
Journal:  J R Soc Med       Date:  2007-05       Impact factor: 5.344

6.  Doctors' perceptions of palliative care for heart failure: focus group study.

Authors:  Barbara Hanratty; Derek Hibbert; Frances Mair; Carl May; Christopher Ward; Simon Capewell; Andrea Litva; Ged Corcoran
Journal:  BMJ       Date:  2002-09-14

7.  Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis.

Authors:  Donna Goodridge; Josh Lawson; Graeme Rocker; Darcy Marciniuk; Donna Rennie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-05-06

8.  A day at a time: caregiving on the edge in advanced COPD.

Authors:  A Catherine Simpson; Joanne Young; Margaret Donahue; Graeme Rocker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

Review 9.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.

Authors:  Morag C Farquhar; Irene J Higginson; Petrea Fagan; Sara Booth
Journal:  BMC Palliat Care       Date:  2009-07-07       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.